AeroLeads people directory · profile
Chris Nowers Email & Phone Number
Member of the Board of Directors
at
Sartorius Stedim Biotech
1 work email found
@onktherapeutics.com
3 phones found area 771 and 310
LinkedIn matched
✓ Verified July 2026
4 data sources
Profile completeness 100%
Current company
Role
Member of the Board of Directors
Location
Del Mar, California, United States
Who is Chris Nowers? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Chris Nowers is listed as Member of the Board of Directors at Sartorius Stedim Biotech, based in Del Mar, California, United States. AeroLeads shows a work email signal at onktherapeutics.com, phone signal with area code 771, 310, and a matched LinkedIn profile for Chris Nowers.
Chris Nowers previously worked as Commercial Launch and Medical Affairs Advisory Board Member at Autolus Therapeutics and Chief Executive Officer and Board Member at Onk Therapeutics. Chris Nowers holds Bachelor Of Science (Bsc) Biochemistry from University Of Kent.
Company email context
Email format at Sartorius Stedim Biotech
This section adds company-level context without repeating Chris Nowers's masked contact details.
{first}.{last}@onktherapeutics.com
86% confidence
AeroLeads found 1 current-domain work email signal for Chris Nowers. Compare company email patterns before reaching out.
Profile bio
About Chris Nowers
A proven leader with experience spanning CEO, European regional leadership, country general management and senior sales and marketing roles (US, Europe and Global). Expertise across multiple therapeutic areas including oncology and hematology (including cell therapy and immuno-oncology), rheumatology, neurology and nephrology. Established experience in fundraising, operations leadership, business development, partner management, IP optimization and company restructuring.
Listed skills include Biotechnology, Pharmaceutical Industry, Oncology, and Life Sciences.
Current workplace
Chris Nowers's current company
Company context helps verify the profile and gives searchers a useful next step.
22 roles · 41 years
Chris Nowers work experience
A career timeline built from the work history available for this profile.
Commercial Launch And Medical Affairs Advisory Board Member
CurrentAppointed to this Advisory Board to offer my expertise in evaluating and assessing the company's launch preparations, commercialization strategies, and medical affairs initiatives. By leveraging my extensive cell therapy experience in both oncology and autoimmune disease, and my background in autologous CAR-T launch activities, I aim to provide valuable counsel to the company's executives and the broader launch team to assist in ensuring a highly successful launch.
Mar 2023 - Present
Chief Executive Officer And Board Member
CurrentONK Therapeutics is dedicated to optimizing a next generation of off-the-shelf, dual-targeted NK cell therapies for patients with hematologic and solid cancers.The company’s proprietary NK cell therapy platform is based on a dual-targeted construct, combining a chimeric antigen receptor (CAR) targeting a known tumor antigen, with a TRAIL variant targeting the death receptor pathway through DR4 or DR5. This dual-targeted approach has the potential to improve efficacy and be less vulnerable to antigen escape.This platform could be broadly applicable across a wide range of targets and tumor types, with the potential to bring significant therapeutic benefit.
Oct 2020 - Present
Chief Executive Officer And Board Member
Aug 2018 - Feb 2020
Head Of Europe
Sep 2016 - Sep 2018
Head Of France Oncologie-Hématologie
Jun 2014 - Sep 2016
Vice President Global Commercialization - Yervoy
Dec 2011 - Jun 2014
Vice President, Early Oncology Global Commercialization
Bristol-Myers Squibb is a global BioPharma company firmly focused on its Mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis and psychiatric disorders.At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this strategy, we focus on our customers’ needs, giving maximum priority to accelerating pipeline development, delivering sales growth and continuing to manage costs.
Jun 2011 - Dec 2011
Vice President Sales And Marketing
Genomic Health, a life science company founded in August of 2000 and located in Redwood City, California, is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services. To that end, the company conducts sophisticated genomic research to develop clinically-validated molecular diagnostics which provide individualized information on response to certain types of therapy, as well as the likelihood of disease recurrence. These diagnostic technologies generate information that healthcare providers and patients can use in making treatment decisions.
Jan 2009 - Jun 2011
Ceo
Avantogen Oncology, Inc.
Publicly traded biotech company, focussed on early clinical development of oncology drug candidates. Lead candidate was RP101, a nucleoside analogue under investigation as an adjunct to chemotherapy in the treatment of patients with pancreatic cancer. RP101 was successfully out-licensed to SciClone Pharmaceuticals, Inc., Foster City, CA.
2006 - 2007
~1 yr
Us Brand Director, Nephrology
2004 - 2006
~2 yrs
Global Commercial Leader, Neurology
2003 - 2004
~1 yr
European Business Director, Rheumatology
2002 - 2003
~1 yr
General Manager, Nordic Region
2001 - 2002
~1 yr
European Associate Director, Oncology
1999 - 2001
~2 yrs
European Marketing Manager, Oncology
1996 - 1999
~3 yrs
European Product Manager, Oncology
1994 - 1996
~2 yrs
Uk Senior Product Manager, Respiratory
1993 - 1994
~1 yr
Uk Product Manager, Oncology
1991 - 1993
~2 yrs
Uk Sales And Marketing Executive
1989 - 1991
~2 yrs
Uk Sales Representative
1987 - 1989
~2 yrs
Uk Sales Representative
The Wellcome Foundation
1986 - 1987
~1 yr
2 education records
Chris Nowers education
Bachelor Of Science (Bsc) Biochemistry
University Of Kent
Higher National Diploma (Hnd) Biology
Brighton Center Of Applied Biology
FAQ
Frequently asked questions about Chris Nowers
Quick answers generated from the profile data available on this page.
What company does Chris Nowers work for?
Chris Nowers works for Sartorius Stedim Biotech.
What is Chris Nowers's role at Sartorius Stedim Biotech?
Chris Nowers is listed as Member of the Board of Directors at Sartorius Stedim Biotech.
What is Chris Nowers's email address?
AeroLeads has found 1 work email signal at @onktherapeutics.com for Chris Nowers at Sartorius Stedim Biotech.
What is Chris Nowers's phone number?
AeroLeads has found 3 phone signal(s) with area code 771, 310 for Chris Nowers at Sartorius Stedim Biotech.
Where is Chris Nowers based?
Chris Nowers is based in Del Mar, California, United States while working with Sartorius Stedim Biotech.
What companies has Chris Nowers worked for?
Chris Nowers has worked for Sartorius Stedim Biotech, Autolus Therapeutics, Onk Therapeutics, Cell Medica, and Kite Pharma.
How can I contact Chris Nowers?
You can use AeroLeads to view verified contact signals for Chris Nowers at Sartorius Stedim Biotech, including work email, phone, and LinkedIn data when available.
What schools did Chris Nowers attend?
Chris Nowers holds Bachelor Of Science (Bsc) Biochemistry from University Of Kent.
What skills is Chris Nowers known for?
Chris Nowers is listed with skills including Biotechnology, Pharmaceutical Industry, Oncology, and Life Sciences.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial